Unaudited Financial Results of the Company for half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deepak Chemtex reported a weaker first half of FY26. Standalone revenue from operations fell to ₹2,698.78 lakhs from ₹3,270.76 lakhs in H1 FY25, a drop of about 17.5%. Profit before tax slipped to ₹441.31 lakhs from ₹691.12 lakhs, and net profit declined to ₹342.99 lakhs (₹525.01 lakhs earlier), pushing EPS down to ₹3.16 from ₹4.83. On a consolidated basis (including DCL Speciality Chemicals, South West Chemicals, and Atlas Tints), revenue came in at ₹3,092.68 lakhs versus ₹3,885.99 lakhs, with PAT at ₹432.97 lakhs vs ₹563.56 lakhs. Operating cash flow swung to a positive ₹292.55 lakhs from negative ₹71.34 lakhs, and the auditor Mittal & Associates issued an unqualified limited review report. The company also confirmed that IPO proceeds of ₹2,304 lakhs have been fully utilised as per the stated objects.
Shareholders should note a clear slowdown in both top line and bottom line compared with the year-ago period, with margins under pressure. The positive flip in operating cash flow and full deployment of IPO funds for plant and working capital are encouraging signs, but near-term earnings momentum looks soft.